DETERMINATION OF THE SPECIFICITIES OF MONOCLONAL-ANTIBODIES RECOGNIZING MEMBERS OF THE CEA FAMILY USING A PANEL OF TRANSFECTANTS

被引:51
作者
DANIEL, S
NAGEL, G
JOHNSON, JP
LOBO, FM
HIRN, M
JANTSCHEFF, P
KUROKI, M
VONKLEIST, S
GRUNERT, F
机构
[1] IMMUNOTECH SA,MARSEILLE,FRANCE
[2] FUKUOKA UNIV,SCH MED,DEPT BIOCHEM,FUKUOKA 81401,JAPAN
[3] UNIV MUNICH,INST IMMUNOL,W-8000 MUNICH 2,GERMANY
[4] UNIV FREIBURG,INST IMMUNOBIOL,STEFAN MEIER STR 8,D-79104 FREIBURG,GERMANY
关键词
D O I
10.1002/ijc.2910550222
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinoembryonic antigen (CEA), one of the most clinically important tumor markers, is mainly used in the post-surgical surveillance of patients with colorectal carcinomas. CEA belongs to a large protein family, which includes cross-reacting antigens, e.g., non-specific cross-reacting antigens (NCAs) and biliary glycoprotein (BGP) as well as pregnancy-specific glycoproteins (PSGs). The genes encoding these proteins can be subdivided into the CEA and PSG subgroups. The members of the subgroups share antigenic determinants and show high similarity in amino-acid sequences. Their derived secondary structures show them to belong to the immunoglobulin superfamily. Due to the close relationship of the members of the CEA subgroup, it is very difficult to distinguish between the individual members with MAbs. Here we have used flow cytometric analysis of transfectants expressing individual members of the CEA subgroup as an alternative approach to determine the specificities of 13 MAbs. This allows us to examine the specificities of these antibodies for members of the CEA family, even of those which have not yet been characterized at the protein level. In addition, binding of the MAbs to NCAs expressed by polymorphonuclear cells (PMN) was tested by Western-blot analysis, immunoprecipitation and flow cytometry. Four antibodies bound exclusively to NCA-50/90 and one MAb (80H3) only to NCA-95. MAb 4/3/17 recognizes CEA and BGP on the surface of transfectants and NCA-160 from granulocytes. We assume that NCA-160 is a product of the BGP gene. On granulocytes, which do not express CEA, MAb 4/3/17 is specific for NCA-160 (BGP). Mutual inhibition of the MAbs binding to NCA-50/90 revealed 3 different epitope groups. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:303 / 310
页数:8
相关论文
共 27 条
[1]  
ANTSCHEFF P, 1991, BIOMED BIOCHIM ACTA, V50, P1261
[2]   MONOCLONAL-ANTIBODY AGAINST CARCINOEMBRYONIC ANTIGEN (CEA) IDENTIFIES 2 NEW FORMS OF CROSS-REACTING ANTIGENS OF MOLECULAR-WEIGHT 90,000 AND 160,000 IN NORMAL GRANULOCYTES [J].
AUDETTE, M ;
BUCHEGGER, F ;
SCHREYER, M ;
MACH, JP .
MOLECULAR IMMUNOLOGY, 1987, 24 (11) :1177-1186
[3]  
BERLING B, 1990, CANCER RES, V50, P6534
[4]   MONOCLONAL-ANTIBODIES IDENTIFY A CEA CROSSREACTING ANTIGEN OF 95-KD (NCA-95) DISTINCT IN ANTIGENICITY AND TISSUE DISTRIBUTION FROM THE PREVIOUSLY DESCRIBED NCA OF 55-KD [J].
BUCHEGGER, F ;
SCHREYER, M ;
CARREL, S ;
MACH, JP .
INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (05) :643-649
[5]   IDENTIFICATION OF MEMBRANE-ANTIGENS IN GRANULOCYTES AND COLONIC-CARCINOMA CELLS BY A MONOCLONAL-ANTIBODY SPECIFIC FOR BILIARY GLYCOPROTEIN, A MEMBER OF THE CARCINOEMBRYONIC ANTIGEN FAMILY [J].
DRZENIEK, Z ;
LAMERZ, R ;
FENGER, U ;
WAGENER, C ;
HAUBECK, HD .
CANCER LETTERS, 1991, 56 (02) :173-179
[6]   DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES [J].
GOLD, P ;
FREEDMAN, SO .
JOURNAL OF EXPERIMENTAL MEDICINE, 1965, 121 (03) :439-+
[7]  
GOTTLINGER HG, 1988, CANCER RES, V48, P2198
[8]   2 CEA AND 3 NCA SPECIES, ALTHOUGH DISTINGUISHABLE BY MONOCLONAL-ANTIBODIES, HAVE NEARLY IDENTICAL PEPTIDE PATTERNS [J].
GRUNERT, F ;
ABUHARFEIL, N ;
SCHWARZ, K ;
VONKLEIST, S .
INTERNATIONAL JOURNAL OF CANCER, 1985, 36 (03) :357-362
[9]   PROTEIN-ANALYSIS OF NCA-50 SHOWS IDENTITY TO NCA CDNA DEDUCED SEQUENCES AND INDICATES POSTTRANSLATIONAL MODIFICATIONS [J].
GRUNERT, F ;
KOLBINGER, F ;
SCHWARZ, K ;
SCHWAIBOLD, H ;
VONKLEIST, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 153 (03) :1105-1115
[10]  
HAMMARSTROM S, 1989, CANCER RES, V49, P4852